New Delhi, April 27 (IANS) India’s major drugmaker Sun Pharmaceutical Industries on Monday announced that it will acquire New York-listed Organon & Co in an all-cash deal valued at $11.75 billion, its biggest overseas acquisition to date.Under the agreement, the pharmaceutical firm will acquire 100 per cent of Organon’s outstanding shares at $14 per share, translating into an enterprise valuation of $11.75 billion and an equity value of around $3.99 billion, the company said in an exchan…
Trending
- Operation Safed Sagar Review 2026: A Powerful Tribute To Kargil’s Air Warriors
- DC Movie Review 2026: Wamiqa Gabbi’s Fierce Performance Make This Saga a Massive Triumph
- Korean Kanakaraju Movie Review 2026: An Unmissable Cross-Border Ride
- Ohh My Dog Movie Review 2026: A Heartwarming Triumph Of Loyalty & Love
- G.D.N. Movie Review: Madhavan’s Powerhouse Biopic Is a Tribute to India’s Forgotten Edison
- Adhey Neevu Adhey Nenu 2026 Movie Review: A Love Triangle That Hides a Deadly Secret
- Hanuman Ansh 2026 Movie Review: A Soul-Stirring Tribute That Will Move You to Tears
- Karmakhya 2026 Movie Review: Samuthirakani’s Brilliant Performance Powers This Thriller
